1. Home
  2. HUN vs ADMA Comparison

HUN vs ADMA Comparison

Compare HUN & ADMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Huntsman Corporation

HUN

Huntsman Corporation

N/A

Current Price

$9.62

Market Cap

1.8B

Sector

Industrials

ML Signal

N/A

Logo ADMA Biologics Inc

ADMA

ADMA Biologics Inc

N/A

Current Price

$9.59

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HUN
ADMA
Founded
1970
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
2004
2012

Fundamental Metrics

Financial Performance
Metric
HUN
ADMA
Price
$9.62
$9.59
Analyst Decision
Hold
Strong Buy
Analyst Count
11
4
Target Price
$12.09
$25.67
AVG Volume (30 Days)
2.1M
2.0M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
2.64%
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.35
Revenue
$5,683,000,000.00
$42,219,783.00
Revenue This Year
$3.08
$27.46
Revenue Next Year
$5.27
$22.11
P/E Ratio
N/A
$27.23
Revenue Growth
N/A
43.85
52 Week Low
$7.30
$7.21
52 Week High
$16.09
$20.46

Technical Indicators

Market Signals
Indicator
HUN
ADMA
Relative Strength Index (RSI) 36.70 53.02
Support Level N/A $9.24
Resistance Level $10.60 $10.24
Average True Range (ATR) 0.32 0.27
MACD 0.02 -0.05
Stochastic Oscillator 5.06 34.44

Price Performance

Historical Comparison
HUN
ADMA

About HUN Huntsman Corporation

Huntsman Corp is a USA-based manufacturer of differentiated organic chemical products. The product portfolio of the company comprises Methyl diphenyl diisocyanate (MDI), Amines, Maleic anhydride, and Epoxy-based polymer formulations. The company's products are used in adhesives, aerospace, automotive, and construction products, and others. Its operating segments are Polyurethanes, Performance Products, and Advanced Materials. The company derives the majority of its revenue from the Polyurethanes segment, which includes MDI, polyols, TPU (thermoplastic polyurethane), and other polyurethane-related products. Its geographical segments are the United States & Canada, Europe, Asia-Pacific, and the Rest of the world.

About ADMA ADMA Biologics Inc

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Share on Social Networks: